{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910300211303321"]
[null,null,"Titolo",null,"Chronic Kidney Disease and Hypertension / / edited by Matthew R. Weir, Edgar V. Lerma"]
[null,null,"Pubbl/distr/stampa",null,"New York, NY : , : Springer New York : , : Imprint : Humana, , 2015"]
[null,null,"ISBN",null,"1-4939-1982-2"]
[null,null,"Edizione",null,"[1st ed. 2015.]"]
[null,null,"Descrizione fisica",null,"1 online resource (260 p.)"]
[null,null,"Collana",null,"Clinical Hypertension and Vascular Diseases"]
[null,null,"Disciplina",null,"616.1"]
[{"$nulls":4},"616.132"]
[null,null,"Soggetti",null,"Cardiology"]
[{"$nulls":4},"Nephrology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future -- Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD -- Resistant hypertension in patients with chronic kidney disease -- Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease -- Novel Molecules -- Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean? -- Renal Sympathetic Denervation -- Novel baroreceptor activation therapy -- Blood Pressure Vaccines -- Masked Hypertension: Does it Lead to CVD or CKD? -- White Coat Hypertension- Do We Really Understand It Now? -- Uric Acid And Hypertension - Is There Really A Link?.-  Preeclampsia: Angiogenic factors, blood pressure, and the kidney -- Inflammation and Hypertension -- Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations -- Endocrine Hypertension and Chronic Kidney Disease -- Hypertension in Children with Chronic Kidney Disease -- Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link."]
[null,null,null,"Sommario/riassunto","The treatment of hypertension has become the most important intervention in the management of all forms of chronic kidney disease. Chronic Kidney Disease and Hypertension is a current, concise, and practical guide to the identification, treatment and management of hypertension in patients with chronic kidney disease.  In depth chapters discuss many relevant clinical questions and the future of treatment through medications and or novel new devices. Written by expert authors, Chronic Kidney Disease and Hypertension provides an up-to-"]
[{"$nulls":4},"date perspective on management and treatment and how it may re-shape practice approaches tomorrow."]